Julia Rasooly, MS
Founder/ Chief Executive Officer
Ms. Rasooly has over twelve years of experience in R&D in medical device and biotech industries. She is focused on revolutionizing the dialysis industry and bringing her novel home dialysis technology to make dialysis at home safer and more affordable. Prior to being the Founder and CEO of PuraCath Medical, she was a researcher at the renowned Molecular Imaging Laboratory at Stanford University School of Medicine, where she worked on stem cell therapy and imaging projects. …
Richard Ferrari, MBA
Rich Ferrari is the Co-Founder of De Novo Ventures, one of the renowned venture funds with focus on funding medical devices and biotechnology companies. Rich is a serial medical device entrepreneur himself. He has served as CEO for two publicly traded medical technology companies in the past. Boston Scientific acquired his Cardiovascular Imaging Systems, the leading developer of ultrasound imaging catheters, for $125 million. In addition, CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery was acquired by Guidant for $350 million. Mr. Ferrari was also co-founder of Medical Technology Group, which spun-out Integrated Vascular Systems that was acquired by Abbot Vascular, and Ensure, which was acquired by J&J. Rich is a serial entrepreneur and has strong skills in entrepreneur coaching, inspiring and mentoring first time CEOs and investors on how to achieve the most from their organization.
Michael Rasooly, MS
Mr. Rasooly holds over 25 years of experience in engineering design and product development. He holds an M.S. in engineering, and his expertise lies in designing novel engineering products. He brings his unsurpassed vision and development acumen. He has received multiple awards and distinctions for his engineering designs, and brings to PuraCath Medical his extensive engineering insight and experience, as well as business strategy and business development. …